MedPath

A single arm prospective observational study to analyze Type 2 Diabetes Glucose biomarkers with daily prick tests.

Not Applicable
Conditions
Health Condition 1: E11- Type 2 diabetes mellitus
Registration Number
CTRI/2021/08/035618
Lead Sponsor
Klick Inc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants who are diagnosed with T2D must have a confirmation according to their latest medical records from a certified physician

No restrictions on gender or ethnicity will be implemented

Participants must speak English fluently (no restrictions on language accent)

Subjects willing to give written informed consent

Subjects able to comply with the study protocol

Exclusion Criteria

Any person below the age of 18 years or above the age of 60 years

Suspected or confirmed pregnancy

Currently breastfeeding

Diagnosis of any known chronic or acute medical disease other than T2D (e.g., cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)

Diagnosis of any known neurological disease or psychological disorder of any kind (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)

Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)

Use of antibiotics in the three months prior to enrollment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath